Thioacetazone

Drugbox
IUPAC_name = N- [4- [(carbamothioylhydrazinylidene) methyl] phenyl] acetamide


CAS_number=104-06-3
ATC_prefix=J04
ATC_suffix=AM04
ATC_supplemental=
PubChem=
DrugBank=
C=10 | H=12 | N=4 | O=1 | S=1
molecular_weight = 236.3
bioavailability=
metabolism =
elimination_half-life=
excretion =
pregnancy_category =
legal_status =
routes_of_administration= Oral

Thioacetazone(INN and BAN) is also called thiocetazone, thiacetazone, thiosemicarbazone, benzothiozane or amithiozone(USAN); abbreviated T.

Thioacetazone is used in the treatment of tuberculosis; it has only weak activity against "Mycobacterium tuberculosis" and is only useful in preventing resistance to more powerful drugs like isoniazid and rifampicin. It is never used on its own to treat tuberculosis; it is used in a similar way to ethambutol. Thioacetazone is the only anti-TB drug that is ineffective when given intermittently.

There is no advantage to using thioacetazone if the regimen used already contains ethambutol, but many countries in sub-Saharan Africa still use thioacetazone because it is extremely cheap. Use of thioacetazone is declining because it can cause severe (sometimes fatal) skin reactions in HIV positive patients.cite journal
author=Rieder HL, Arnadottir T, Trebucq A, Enarson DA
title=Tuberculosis treatment: dangerous regimens?
journal=Int J Tuberc Lung Dis
year=2001
volume=5
issue=1
pages=1–3
pmid=11263509 ] cite journal
author=Nunn P, Porter J, Winstanley P
title=Thiacetazone—avoid like poison or use with care?
journal=Trans R Soc Trop Med Hyg
year=1993
volume=87
issue=5
pages=578–82
pmid=7505496
doi=10.1016/0035-9203(93)90096-9 ]

References